Parenteral aminoglycoside therapy. Selection, administration and monitoring (Q40392377)

20 September 2017

1 reference

title

Parenteral aminoglycoside therapy. Selection, administration and monitoring (English)

1 reference

ORCID Public Data File 2021

20 September 2017

1 reference

author name string

C R Kumana

series ordinal

1

1 reference

20 September 2017

K Y Yuen

series ordinal

2

1 reference

20 September 2017

language of work or name

1 reference

1 June 1994

1 reference

20 September 2017

1 reference

20 September 2017

volume

47

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

902-913

1 reference

Once versus thrice daily gentamicin in patients with serious infections

20 September 2017

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Aminoglycoside toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Aminoglycoside dosage regimens. Is once a day enough?

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Practicalities of once-daily aminoglycoside dosing

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Clinical pharmacokinetics of antibiotics in patients with impaired renal function

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Enhanced activity of streptomycin and chloramphenicol against intracellular Escherichia coli in the J774 macrophage cell line mediated by liposome delivery

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Combination effect of ceftriaxone with four aminoglycosides on nonfermenting gram-negative bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Serum level monitoring of antibacterial drugs. A review

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Risk Factors for Nephrotoxicity in Patients Treated with Aminoglycosides

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Studies of risk factors for aminoglycoside nephrotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Pharmacokinetics of Gentamicin: Distribution and Plasma and Renal Clearance

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Once-a-day beta-lactam antibiotic administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

The postantibiotic effect induced by antimicrobial combinations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Penicillin-induced post antibiotic effects on streptococci in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Good antimicrobial prescribing. Aminoglycosides

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Streptococcus zooepidemicus (Lancefield group C) septicaemia in Hong Kong

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses. Scandinavian Amikacin Once Daily Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

ABC of monitoring drug therapy. Aminoglycoside antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Netilmicin in the treatment of gram-negative bacteremia: single daily versus multiple daily dosage

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Activity of amikacin and ampicillin in succession and in combination

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Synergistic treatment of enterococcal endocarditis: in vitro and in vivo studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Single-dose antibiotic therapy: what has the past taught us?

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Killing of intraphagocytic Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Once-daily aminoglycoside dosing

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life, and protein binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Human pharmacodynamics of beta-lactams, aminoglycosides and their combination

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Once daily administration of netilmicin compared with thrice daily, both in combination with metronidazole, in gangrenous and perforated appendicitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Once-daily aminoglycoside dosing

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

The comparative pharmacokinetics of 3H-dihydrostreptomycin in solution and liposomal form in normal and Mycobacterium tuberculosis infected mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Continuous versus discontinuous antibiotic therapy: the role of the post-antibiotic effect and other factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

What preclinical data are needed to justify once-daily therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

New dosing regimens for aminoglycoside antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Once-daily aminoglycoside dosing

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

A study of amikacin given once versus twice daily in serious infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Distribution of liposomes in tuberculous mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Role of Antimicrobial Pharmacokinetics and Pharmacodynamics in Surgical Prophylaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

The postantibiotic effect.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Diffusion of univalent ions across the lamellae of swollen phospholipids

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Antimicrobial tolerance in group G streptococci

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Risk factors for the development of auditory toxicity in patients receiving aminoglycosides

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Vancomycin-streptomycin synergism in enterococcal endocarditis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

Clinical pharmacokinetics of newer antibacterial agents in liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/7521830

12 December 2020

10.2165/00003495-199447060-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1024937847

0 references

1 reference